Multiple Myeloma Tumor Board: Use of Novel Agents as Initial Therapy | ASCO Connection

Advertisement

Search

Latest Forum Activity

ASCO in Action
ASCO Emphasizes Quality Improvement, Stability in House SGR Comments read more...
ASCO Admin
ASCO Joins Global Alliance to Enable Responsible Sharing of Genomic and Clinical Data read more...
Conquer Cancer Foundation
Research Presented at ASCO 2013 by CCF Grantee gives Hope to Patients with Thyroid Cancer read more...
Mark O'Rourke
Ethical need for national research registry for targeted therapies read more...
Conquer Cancer Foundation
Study Funded by Conquer Cancer Foundation Identifies a New Therapy for Rare Melanoma of the Eye read more...
ASCO Guidelines
Updated Guideline: Fertility Preservation in Patients with Cancer read more...
ASCO Admin
ASCO U/LIVESTRONG Foundation Videos on Fertility Preservation Discussions read more...
Doug Pyle
New ASCO/CCF Funding for LMCs read more...
ASCO in Action
Apply Now for the New ASCO Quality Training Program read more...
ASCO Admin
Links to the Latest News from the 2013 ASCO Annual Meeting read more...

Welcome to the ASCO Connection Forums

Please read the Forum & Comment Guidelines before proceeding.

Search Home

New Post

5/25/2011 1:55 PM

Joined: 5/25/2011

Posts: 3

Multiple Myeloma Tumor Board: Use of Novel Agents as Initial Therapy Modified By ASCO Admin on 9/26/2012 11:47:21 AM

Modified By ASCO Admin on 9/26/2012 11:47:21 AM

Is there evidence to support the use of novel agents in the initial therapy of newly diagnosed multiple myeloma?

Page 1 of 1

Log in required to see "reply" and "create thread" links.

Name:

Email:

Subscribe

ASCO.org • Conquer Cancer Foundation • Cancer.Net • Journal of Clinical Oncology • Journal of Oncology Practice • ASCO University • Quality Oncology Practice Initiative (QOPI)

© 2005-2011 American Society of Clinical Oncology (ASCO). All rights reserved worldwide. | 2318 Mill Road, Suite 800, Alexandria, VA 22314 | phone: (571) 483-1300